With this new conceptual perspective, for corneal ulcer healing, this therapy perspective was now reviewed compared to standard existing eye therapies (i.e., anti-VEGF agents, corticosteroids, EGF, NGF, and others) used in corneal ulcer healing, therapy of neovascularization, and glaucoma therapy. The gene discussed is VEGFA; the disease is glaucoma.